Family Medicine Government Governments Innovation Medical Specialties News Pharma & Biotechnology

France Limits Paracetamol Sales as Hoarding Threatens Availability

France limited sales of paracetamol -based drugs on Tuesday as people who fear coronavirus infection raided pharmacies to stockpile the drug.

France’s ANSM medicine agency said that while this medicine is useful to alleviate aches and fevers in case of coronavirus infection, people should not unnecessarily buy large stocks of the drug.

ANSM said in a statement that in order to guarantee availability of the medicine, pharmacists can sell maximum one box of paracetamol (500 milligram or one gram) to people who do not have symptoms of coronavirus infection and maximum two boxes to patients who do have symptoms.

It also suspended sales on the internet of medicines based on paracetamol, ibuprofen and aspirin.

ANSM said that in case of infection, paracetamol is better than anti-inflammatory drugs such as ibuprofen and these can mask an infection and possibly worsen a patient’s condition.

Used well, it is a safe and efficient drug, the agency said, but it warned that an overdose can cause serious liver damage.

Paracetamol is one of the world’s most common painkillers and is sold under different brand names.

This article was originally published on Reuters

Meeta Ramnani
Meeta Ramnani
Meeta develops credible content about various markets based on deep research, opinions from experts and inputs from industry leaders. As the managing editor at Smart Industry News, she assures that every piece of news and article adds to the knowledge of decision makers. An avid bike rider, Meeta, is a postgraduate from Indian Institute of Journalism and New Media (IIJNM) Bangalore, where her specialization was Business Journalism. She carries experience from mainstream print media including The Times Group and Sakal Media Group.
https://smarthealthcarenews.com/